Response from QBL Management, page-2

First 2 Last

Share
Profile

Follow
WagonR

100 Posts.

13

12/04/18

09:58

Post #: 32398945
Share

Originally posted by Neil1959 ↑

ANSWERS FROM QBL MANAGEMENT

@WagonR
" An additional 50 million performance shares will be issued to the vendor shareholders of MCL upon MCL obtaining a permit from the Australian Government to grow cannabis varieties for medical cannabis research leading to product development. These performance shares will also be subject to shareholder approval under Listing Rule 7.1 of the ASX Listing Rules."

So does that mean that Andrew and the other shareholders of MCL will NOT be issued these 50 Million shares now that QBL/MCL are not pursuing a MM License? a bit of a "grey" area?
Q: @sarg187
Great question @WagonR . Thanks for visiting previous announcemnt.
@Neil1959, can you please get clarification from management what will happen to this 50 mil performance share to MCL?

A: To clarify the confusion, management has not said that a local medical license is not being pursued at all, only that it is not needed to be pursued as a priority, as that license is not needed by the company in the short term due to the current research and product development being done for the company by far more advanced overseas partners in more advanced jurisdictions. The 50M performance shares were issued to the MCL shareholders as part of the original agreement, they will convert to ordinary shares once the company does get the local medical cultivation license. As you can see it is in Andrew's interest for that to happen, but it won't happen at the expense of shareholders, but in due course as and when it is appropriate or needed for the company to secure the license. A number of options are being looked at by the company to secure these licenses without significant expense or time, and the company will report to the ASX any material details of these options as and when they become relevant.

Cheers....59

Expand

Thanks Neil. Why can't QBL Management post these info to the ASX instead of us having to ask thru U on HC? as I mentioned before, not all QBL investors ( plus potential new) read HC. QBL/ MCL is a relatively new and there should be updates on what is to happen and not only once a month! MCL is the only reason QBL SP has increased since March 2017 and not Bauxite.

QBL Price at posting: 3.6¢ Sentiment: Hold Disclosure: Held
8 Upvote

0 Great analysis

Reply

Top Stories

Week 36 Wrap: AI hype wave tested again; Oz per capita recession continues; AirTrunk’s $40B+ payday

QML

Metallurgical testing shows saleable copper and pyrite from QMines' Develin Creek project

BIT

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

PRU

Perseus Mining boosts stake in Predictive Discovery to 19.9% as latter's flagship project stalls

RMX

Red Mountain Mining: record gold prices, two projects, two greenstone belts

CBA breaks trading record on strong day for Aussie financials

OCC

Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil

SBW

Shekel Brainweigh investor presentation webinar – the future of retail automation

As Nvidia cools, we're looking to Aussie AI

LAM

Laramide sniffs prime Kazakh uranium, with agreement over 6000 square km land position

There are more pages in this discussion • 28 more messages in this thread...

First 2 Last

Add CGB (ASX) to my watchlist

Response from QBL Management, page-2

Top Stories

Week 36 Wrap: AI hype wave tested again; Oz per capita recession continues; AirTrunk’s $40B+ payday

Metallurgical testing shows saleable copper and pyrite from QMines' Develin Creek project

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

Perseus Mining boosts stake in Predictive Discovery to 19.9% as latter's flagship project stalls

Red Mountain Mining: record gold prices, two projects, two greenstone belts

CBA breaks trading record on strong day for Aussie financials

Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil

Shekel Brainweigh investor presentation webinar – the future of retail automation

As Nvidia cools, we're looking to Aussie AI

Laramide sniffs prime Kazakh uranium, with agreement over 6000 square km land position

Featured News